Our Origins

Nura Bio was conceived in 2018 by The Column Group and its scientific founders to revolutionize the treatment of neurological diseases with novel, life-changing neuroprotective medicines.

Breaking new ground for neuroprotective therapies

By transforming recent scientific breakthroughs in axonal degeneration and neuroimmune regulation into neuroprotective medicines, we aim to offer renewed hope for those affected by serious neurological diseases.

Learn More

Leadership Team

Nura Bio’s team of leading biologists, chemists, and drug developers is uniquely qualified to tackle the immense challenge of halting neurological disease. Bound by shared passion for our mission and recognition of the urgency it demands, we are determined to revolutionize the treatment of neurological diseases and the lives of people affected by them.